With its high diagnostic efficacy, ease of use, and reproducibility, as well as its objectivity and noninvasiveness, DCP is an ideal marker that could be considered an easily accessible complement of US for the surveillance for HBV-related HCC. Here, ACE is linked to hepatocellular carcinoma.